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Abstract 
Magnesium and its alloys are used for biomaterials in orthopedic applications. Such alloys are still under development, and they are used due to their 
biocompatibility and mechanical (bone-like) properties that make them suitable to be used as biomaterials. Magnesium has potential to be used in 
biodegradable implants because of its capacity to support tissue regeneration processes. Therefore, multiple strategies have been developed to enhance 
magnesium properties. Coatings on magnesium alloys have been used to improve the cytocompatibility and corrosion resistance of magnesium. 
Particularly, titanium dioxide can be used as coating on magnesium to help regulating degradation rate and overcome some issues when magnesium is 
inserted into the human body. Accordingly, this paper is a critical review to consolidate the available literature about titanium dioxide coatings on 
magnesium alloys for potential use as biomaterials. The work focuses on coatings obtained by the sol-gel route as a promising technique for biomedical 
applications. 
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Recubrimientos de dioxido de titanio sobre aleaciones de magnesio 
para biomateriales: Una revisión  
Resumen 
El magnesio y sus aleaciones, que aún se encuentran en desarrollo, se usan en aplicaciones ortopédicas debido a su biocompatibilidad y propiedades 
mecánicas (similares al hueso), que los hacen adecuados para aplicaciones en biomateriales. El magnesio tiene potencial para ser usado en implantes 
biodegradables dada su capacidad de soportar los procesos de regeneración de tejidos. En consecuencia, se han desarrollado varias estrategias para 
mejorar las propiedades del magnesio. Los recubrimientos sobre magnesio se emplean para mejorar su citocompatibilidad y resistencia a la corrosión. 
Específicamente, el dióxido de titanio se puede usar como recubrimiento protector sobre el magnesio, con el fin de ayudar a regular la velocidad de 
degradación y superar algunos problemas que se encuentran cuando el magnesio es implantado en el cuerpo. Por tanto, en este artículo se realizó una 
revisión crítica para consolidar la literatura disponible acerca de recubrimientos de dióxido de titanio sobre aleaciones de magnesio para potenciales 
aplicaciones en biomateriales. En este documento se hace énfasis en los recubrimientos obtenidos por medio de la de la ruta sol-gel como técnica 
prometedora para aplicaciones biomédicas. 
Palabras clave: Aleaciones de magnesio; dióxido de titanio; modificación superficial; recubrimientos; biomédico. 
1. Introduction
Biomaterials are either natural or synthetic materials used
to replace or assist an organ or tissue. They are in direct 
contact with biological systems [1] and they must be 
biocompatible. Biocompatibility was defined in 2008 as "the 
How to cite: Hernández-Montes, V., Betancur-Henao, C.P. and Santa-Marín, J.F., Titanium dioxide coatings on magnesium alloys for biomaterials: A review, DYNA 84(200), 
pp. 261-270, 2017. 
ability of a material to perform the required function in 
response to medical therapy without causing undesired 
effects at either the local or systemic level in a user. The 
material must also produce a proper cell or tissue response in 
order to create relevant clinical therapy" [2]. Moreover, a 
biocompatible material can be inert or can interact and react 
with the tissue. Other biocompatible materials are degraded 
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by the body over time, and the adaptation of the material 
response to the body is decisive. Biocompatibility then 
assesses the biological activity of the material after being in 
contact with human tissue. Accordingly, a biocompatible 
material must not be genotoxic, cytotoxic, mutagenic, 
carcinogenic, or immunogenic [3]. Biomaterials have been 
developed in four different generations, and they are grouped 
according to clinical requirements. Inert biomaterials have 
been developed and selected since 1950 to enhance repair 
processes or replacement of the host tissue without causing 
an adverse reaction in the biological system; these materials 
were called first-generation biomaterials. They included 
cobalt alloys, alumina, and stable polyurethane and had great 
importance in orthopedic and dental applications. 
The second generation of biomaterials started due to poor 
adhesion and implant loosening, which called for the 
development and use of materials with bioactive surfaces 
capable of forming complex bonds with the tissue. At the same 
time, the use of biodegradable materials was also being 
researched; thus, since 1970, materials with bioactive or 
biodegradable properties have been studied. Titanium and 
calcium phosphates, including hydroxyapatite, are examples of 
second-generation biomaterials. However, the materials 
mentioned above showed limited durability over time. Further 
research is based on finding temporary materials capable of 
being degraded in a controlled manner over time and promoting 
a natural integration of the implant with the tissue that they 
should eventually replace. Bioactivity and biodegradation 
properties of third-generation materials such as magnesium and 
its alloys are currently under study for tissue regeneration and 
cardiovascular stents [1]. Since around 2010, researchers began 
studying a new generation of biomaterials. This latest 
generation of biomaterials encompasses biomimetic 
nanocomposites for applications in tissue engineering [4]. Fig. 
1. shows the four generations of biomaterials [5]. 
Currently, biomaterials science is focused on the 
development of temporary degradable structures allowing 
tissue integration with the implant, in order to improve the 
replacement or repair process. After repair, the implant is 
degraded and it is replaced by host tissue. Consequently, 
degradable biomaterials for bone repair are generating much 
interest —because they can save additional implant removal 
procedures, reducing pain and health care costs. 
On one hand, biodegradable or resorbable polymers such as 
poly(lactic-co-glycolic acid) (PLGA), polylactic acid (PLA), and 
polyglycolic acid (PGA) are currently being clinically applied. 
However, they have shown adverse effects in the human body 
when the immune system triggers osteolytic reactions around 
 
 
Figure 1. Evolution of biomaterials. 
Source: adapted from Bedilu et al. 2012. 
the implant after a foreign body —for example, a 
polymer— is recognized [6,7]. 
On the other hand, magnesium alloys are a new class of 
promising materials currently under development [8]. 
Magnesium alloys exhibit poorer corrosion resistance in Cl--
containing physiologic environments. Thus, these alloys 
could be used as biodegradable metals. Moreover, 
magnesium is essential to human metabolism, and it is the 
fourth most abundant cation in the human body [9]. 
Biodegradable magnesium-based materials usually have a 
high corrosion or biodegradation rate. Since this degradation 
occurs in the early stages of implantation [10,11], this is a 
limitation for using it in biomedical implants. The high 
degradation rate of Mg presents several problems: 1. 
Production of subcutaneous hydrogen bubbles during the 
corrosion of the metal can cause accumulation of hydrogen 
around the implant. Hydrogen can affect the healing process 
and may lead to tissue necrosis due to formation of gaps 
between the implant and the tissue [10,12,13]. 2. Changes in 
local pH values caused by generation of OH- anions during the 
cathodic reaction of the corrosion process [14]. This process 
affects some cellular functions and cell viability [10]. 3. The 
high corrosion rate of magnesium also produces an early 
degradation of transverse sections of the implants. Due to the 
fact that the time required by the bone to regenerate tissue is 
between 3 and 4 months approximately. During that time the 
implant must maintain mechanical integrity [15]. Nevertheless, 
Mg implants will not withstand the mechanical stresses to 
perform osseointegration if they are corroded. In the literature, 
some authors have reported that the magnesium degradation 
period is shorter than the period required to achieve mechanical 
integrity [16]. Still, the time for the implant to be stable depends 
on several factors, such as type of study (in vivo and in vitro 
studies), material composition, implant location, type of model 
(different animals), and days of evaluation of the in-vivo tests. 
Moreover, since several methods are available for measuring 
degradation rates, it is difficult to obtain correlations with in 
vitro tests. As a result, nowadays there is great interest in the 
surface properties of magnesium and its alloys to achieve 
enhanced corrosion resistance and biocompatibility while 
retaining the bulk properties of the material [17]. 
The corrosion rate of magnesium and magnesium alloys is a 
key factor for the development of new biomaterials to be used in 
resorbable implants. Therefore, coatings have emerged as a 
possible solution, enabling the reduction of degradation at the 
early stages of implanted materials and positively affecting the 
tissue recovery process. Surface modification of magnesium can 
be implemented to prevent electrolytes in the biological medium 
or in electrolyte solutions from degrading the material quickly. 
Titanium dioxide is a ceramic that has been widely used as a 
coating material, mainly because it improves the corrosion 
resistance of the surface-covering material (generally metals and 
alloys) [18,21]. Although magnesium is a bio-inert material, 
several authors have argued that it favors the formation of 
calcium phosphates on its surface, which gives the material 
bioactive properties that can be used in bone applications [22,23]. 
Furthermore, the photocatalytic activity of titanium dioxide 
provides antibacterial properties [24]. 
This paper reviews magnesium modified with Titanium 
dioxide, but it does not focus on the techniques since there  
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Figure 2. Degradation of magnesium in a biological environment. 
Source: adapted from Wu, et al. 2013. 
 
 
are several reviews already available in the literature 
[11,13,25]. Its main goal is to gather information concerning 
the development of titanium coatings to improve the 
properties (corrosion rate and biocompatibility) of 
magnesium for applications in biomaterials. In addition, the 
importance of sol-gel techniques for biomedical coatings is 
highlighted. 
 
2.  Magnesium 
 
Magnesium is a metal of interest for bone applications 
due to the fact that its density (1.74 g / cm3) and its Young’s 
modulus of 45 GPa are very similar to those of human bone 
(1.8-2.1 g / cm3 and 40-57 GPa respectively). Magnesium is 
also very abundant in the human body, and it is essential for 
cells, mainly because it takes part in various metabolic 
processes inside the body. Additionally, it is known as an 
essential ion since it participates in the formation of apatite 
in the bone matrix. Magnesium implants were used for the 
first time in 1878, but it was not until 1990 that they were 
used again in orthopedic applications, when Erwin Payr [26] 
introduced fixator pins, pegs, wires, and nails based on 
biodegradable Mg for treatments on bone fractures. When 
magnesium alloys are used for orthopedic implants, they 
provide adequate mechanical properties, low stress shielding 
effects (to avoid bone resorption), good biocompatibility, and 
a controlled degradation rate [27]. However, interest in 
implants made of magnesium and its alloys gradually 
decreased for a period of time, because they are highly 
susceptible to rapid corrosion in physiological environments, 
limiting their application [28]. This accelerated corrosion 
leads to premature failure of implants, since the support 
needed for tissue healing is not provided. Furthermore, 
production of large amounts of subcutaneous hydrogen 
bubbles and modification of local pH could eventually lead 
to tissue necrosis, as it was shown in a review by Frank Witte 
[28]. Fig. 2. presents the natural process of degradation of 
magnesium in a physiological environment [5]. 
Generally speaking, corrosion of magnesium occurs in 
aqueous solutions and various redox reactions are present, 
depending on the alloying elements. It is known that 
hydrogen and magnesium hydroxide will appear during the 
process. The most common corrosion reactions of Mg are 
shown in eq. (1-3) [30]. 
 
Anodic: Dissolution of metal 
 
→ 2  (1) 
 
Cathodic: Evolution of hydrogen 
 
2 2 → 2  (2) 
________________________________________________ 
Net reaction:   2 →       (3) 
 
Given that magnesium is (electrochemically) one of the 
most active metals and that it consequently has high 
corrosion rates, several alloys have been developed to 
overcome those issues and promote its use in numerous 
applications. Therefore, magnesium alloys are part of the 
third generation of biomaterials and they can be classified in 
different families: Mg-Al, Mg-Ca, Mg-Sr, Mg-Zn, Mg-Si, 
Mg-Sn, Mg-Mn, Mg-Re, and Mg-Ag [31,32]. The most 
commonly used commercial alloys are AZ (Mg-Al-Mn), AM 
(Mg-Al-Mn), AE (Mg-Al-Re), the EZ series (Mg-Zn-Re), 
ZK (mg-Zn-Zr), WE (Mg-RE-Zr), or AX AXJ (Mg-Al-Ca), 
and the AJ series (Mg-Al-Sr) [33]. Different alloys have 
particular advantages for certain applications and their 
properties have been extensively evaluated. The literature 
reports that the corrosion rate increases as temperature 
increases and it decreases with aluminum content [34, 35]. 
Pardo et al. [36] assessed the corrosion behavior of 
commercial alloys AZ31 (3.1% Al, 0.73% Zn, 0.25% Mn), 
AZ80 (8.2% Al, 0.46% Zn, 0.13% Mn), and AZ91D (8.8% 
Al, 0.68% Zn, 0.30% Mn). The authors concluded that an 
increase in aluminum concentration significantly reduces the 
corrosive activity of pure magnesium (99%). They also 
determined that the AZ31 alloy is more corrosion-resistant in 
a solution of sodium chloride (NaCl). 
Since 2000, multiple original papers and reviews have 
reported that magnesium has no adverse effects on the human 
body —mainly because Mg is a trace element of the human 
body— and the corrosion products can be considered 
physiologically beneficial. Yun et al. [37] evaluated the 
biocompatibility of Mg under corrosion effects in 
osteoblasts. The mineralization and cytotoxicity results were 
not significantly affected by the presence of corroded Mg. In 
a comparative study by Witte et al. [28], four commercial 
alloys — AZ31, AZ91, WE43, and LAE442— were 
implanted in guinea pig femurs for 6 and 18 weeks, 
demonstrating the osteoinductive capacity of Mg-based 
materials. Recently, Zhen et al. [38] used the murine 
fibroblasts cell line (L929) to test cell viability in different 
concentrations of Mg2+ at various pH values in a DMEM 
medium, and the results show that there is a considerable 
hemolysis rate. However, the result was found for pH values 
higher than 11, which is above the average physiological pH 
(pH = 7). Additionally, the viability of cells treated with low 
concentrations of Mg2+ (<100 µg / mL) is above 80%, 
showing no significant toxicity to L929 cells. 
Currently, the possible medical applications of 
magnesium have gained more attention [31]. Therefore, 
magnesium has been used for the manufacture of 
biodegradable stents [39,40], in order to avoid diseases such 
as thrombosis and restenosis via drug delivery [41]. Great 
efforts to study biodegradable magnesium —in the form of 
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implants for orthopedic applications— are focused on 
improving the corrosion resistance by surface modification in 
order to provide mechanical stability to the material. This is 
done by favoring the initial attachment and subsequent 
degradation that assist the cicatrization processes. 
 
3.  Coatings for magnesium implants 
 
The surfaces of biomaterials implanted in the human body 
are very important because they are in direct contact with host 
tissue. Additionally, since reactions take place at the 
interface, the capability of the material to be used as 
biomaterial is determined by its surface. 
Due to the fact that most materials are not biocompatible, 
several methods have been used to modify their surface 
properties, in order to improve biocompatibility, 
biofunctionality, topography, and physical-chemical 
properties, enabling the materials to maintain their bulk 
material properties. That can be achieved with surface 
modification, integration, and mechanical attachment to host 
tissue [25]. Besides, the modified surface can be an effective 
barrier against the physiological environment. 
Coatings emerge as possible solutions to highly corrosive 
media, forming films or layers on materials (ceramic or 
polymeric materials). A study by Tang et al. [42] compared 
in-vitro and in-vivo Mg-Zr coatings obtained by micro arc 
oxidation (MAO) and electrophoretic deposition (EPD). The 
authors established that EPD coatings are more corrosion-
resistant than coatings obtained by MAO. The results were 
attributed to differences in the coating structure, mostly 
because cracks or pores were not observed on the surface of 
EPD coatings, while micropores were fully distributed on the 
surface of MAO coatings. However, the cell-material 
interactions were not considered in that study. Although the 
results are satisfactory, the insufficient adhesion of coatings 
is the main obstacle of the EPD technique and its potential 
application. Subsequent studies [43] proposed a coating 
method for the micro arc oxidation and liquid phase 
deposition in order to obtain bioactive coatings on a Mg-Zn-
Ca alloy. The authors stated that an evident improvement was 
obtained in the substrate corrosion resistance, although the 
coating obtained by MAO was porous. 
Several polymers have been used as coatings because 
they enhance the corrosion rate of magnesium and also have 
acceptable biocompatibility. Witecka et al. [44] reported that 
four different biodegradable polymers (PLGA, PLLA, 
PHBV, and PHB) on Mg-2.0Zn-0.98Mn magnesium alloys 
obtained by spin-coating successfully reduced the corrosion 
of the substrate. Likewise, the results indicated that both 
cytocompatibility and cell functionality were improved. Ma 
et al. [45] have reviewed polymeric coatings for magnesium 
and magnesium alloys and gathered additional information. 
Ceramic coatings have also been successfully produced. 
On one hand, Ren et al. [46] used a microwave-assisted 
coating process to obtain a ceramic coating (HA and calcium 
deficient hydroxyapatite -CDHA) on a AZ31 magnesium 
alloy substrate. The authors fabricated uniform coatings in 
less than 10 minutes, and the results showed that those 
coatings improved corrosion behavior, they had good 
cytocompatibility and promoted cellular proliferation after 5 
days of incubation in a cell culture medium. On the other 
hand, ceramic coatings were fabricated by micro arc 
oxidation (MAO) on ZK61 magnesium alloys by Yu et al 
[47]. The authors conclude that corrosion resistance was 
improved by the coating, and that the latter favored the 
precipitation of bone-like apatite on the coating surface after 
immersed in SBF for 14 days. 
Other authors have studied nanostructured coatings on 
magnesium alloys for biomedical applications. Recently, a 
novel bi-layered nanostructured SiO2/Ag-FHAp coating on 
biodegradable magnesium has been successfully synthesized 
by physical vapor deposition (PVD) combined with 
electrodeposition (ED). The results showed high corrosion 
resistance and biocompatibility [48]. 
 
3.1.  Magnesium coated with titanium dioxide 
 
Mechanical and biological fixation to the surrounding 
bone is one of the major concerns regarding orthopedic 
implants. Therefore, current research is focused on surface 
modifications to improve the material’s osteoconductivity, to 
have it act as a structural support and to promote new bone 
formation and growth. Osteoconductivity must be 
complemented with biodegradability because implant 
materials must be reabsorbed or biodegraded into the body, 
in order to enable the new tissue to grow and to provide an 
adequate support [49]. Some calcium phosphates (CaP) —
including hydroxyapatite (HA)— have been proposed to 
improve osseointegration of metal implants [50]. However, 
titanium dioxide has emerged as a potential candidate to 
improve the magnesium surface properties and corrosion 
resistance. 
Titanium dioxide (TiO2) and titanium oxide (IV) are 
metal oxides. TiO2 crystallizes naturally in three main forms: 
rutile, anatase, and brookite. The structure of this oxide is 
based on a titanium atom surrounded by six oxygen atoms in 
a distorted octahedral configuration [51]. Titanium oxide is 
stable and non-toxic to the environment or humans. It also 
has high catalytic activity, high oxidizing power, and it is 
stable against photocorrosion [52]. Furthermore, it presents 
antibacterial properties [24]. Different authors have reported 
that titanium oxide induces the precipitation of bone-like 
apatite or calcium phosphates on its surface [53-55]. Those 
properties make titanium dioxide a suitable candidate for 
bone replacement and reconstruction. 
Coatings with titanium dioxide are well known to have 
antibacterial properties. Guo et al. [56] observed the biocidal 
effect of a porous coating with nanoparticles containing Ag 
and TiO2, obtained by a sol-gel route. Fu and coworkers [57] 
observed the biocidal effect as well when using titanium 
dioxide coatings obtained by sol-gel methods on glass 
substrates. In general, the antibacterial effect of TiO2 has 
been extensively researched and the biological mechanism by 
which this happens is currently under study [24,58] 
Due to their mechanical properties and biocompatibility, 
the uses of titanium dioxide coatings in biomedical sciences 
include drug delivery systems [59-61] and dental and 
orthopedic applications [62-65]. 
Since adequate interaction between the biomaterial and 
the surrounding tissue, as well as biodegradability, are 
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desired properties of an orthopedic implant, magnesium 
alloys coated with titanium dioxide are of interest to 
biomedical sciences. By combining those properties, the 
lifetime of a magnesium implant can be extended and various 
biological processes can be fostered without waiving the 
biodegradation properties. 
Titanium dioxide has been used as protective coating on 
titanium substrates, 316L stainless steel, and other metals 
[66], [67]. In spite of this, it is not easy to deposit TiO2 layers 
onto magnesium alloys due to the low adhesion and low 
homogeneity that some methods of surface modification 
provide [68]. Nevertheless, several authors have successfully 
managed to apply such coatings on magnesium and some of 
those studies are mentioned in the following paragraph. 
In their work, Marin et al. [69] used the atomic layer 
deposition (ALD) technique for four different coatings. TiO2 
/ aluminum mono and multilayers were applied to the 
magnesium AZ31 substrate. The results showed that ALD 
deposition can be successfully used to protect the AZ31 Mg 
alloy from corrosion in aqueous solutions with low 
concentrations of NaCl. It is important to highlight that 
multilayer structures were the most effective against 
corrosion but long deposition times are the main limitation to 
this technique. 
Ceramic coatings containing titanium dioxide 
nanoparticles and organic compounds —such as alginate— 
were placed on the magnesium AZ91D alloy by 
electrophoretic deposition (EPD), thus improving the 
corrosion resistance from 3 to 7 times when compared to 
uncoated magnesium. The results were obtained by 
electrochemical impedance spectroscopy (EIS) [70]. Hu et al. 
[68] produced titanium dioxide coatings onto AZ31 alloys by 
modifying the surface, using liquid phase deposition (LPD) 
followed by an annealing process. The TiO2 coatings —with 
or without annealing treatment— decreased the magnesium 
alloy degradation rate, compared to uncoated magnesium in 
electrochemical tests. Fujita and coworkers [71] researched 
the corrosion resistance of TiO2 commercial films on Mg by 
liquid phase deposition (LPD) and they found that by 
changing the solution’s pH —from acidic to highly alkaline 
along with the addition of sucrose— it becomes possible to 
form a highly adhesive and thin TiO2 film on pure 
magnesium without any heat treatment. 
Recently Chen et al. [18] produced layers of 
polydopamine (PDA) between the TiO2 coatings and the Mg 
substrate to improve magnesium corrosion resistance. 
Covalently-immobilized PDA layers on Mg and TiO2 were 
obtained by deposition in liquid phase. The hybrid coating 
exhibited a significantly lower corrosion current, as well as a 
very low rate of in-vitro degradation (up to 21 days) in 
phosphate-buffered saline (PBS), compared to plain TiO2 
coatings. 
Meanwhile, Li et al. [72] studied the mechanical 
degradation of Mg-Ti composites in Hanks solution. For that 
purpose, they used titanium wires embedded in the 
magnesium matrix, employing the infiltration casting 
technique. The authors concluded that magnesium in the 
composite degrades more rapidly than pure magnesium. 
However, the strength of the composite was maintained at 
about 86 MPa after the Mg dissolved. Conversely, 
Bakhsheshi-Rad et al. [73] synthesized a nanostructured 
coating with hardystonite (HT) and titania/hardystonite onto 
Mg alloys. The results indicate that the degradation resistance 
of the magnesium alloys was improved, compared to an 
uncoated magnesium sample. It is emphasized that the cell 
viability was not affected by the exposure of the Mg coating 
with titania/hardystonite to preosteoblastic cells (MCT3-E1). 
Thus, the authors proposed new techniques to obtain coatings 
on the substrate, in order to control the corrosion rate. Similar 
data have been reported by Abdal-hay and coworkers [74]: 
titanium dioxide / poly (lactic acid) coatings on magnesium 
were used for biomedical applications, and they also showed 
a significant reduction of the biodegradation rate and 
hydrogen evolution of the magnesium substrate. These 
coatings were fabricated by electron beam physical vapor 
deposition (EB-PVD). 
Micro arc oxidation has also been used to obtain porous 
surfaces of magnesium, followed by a TiO2 coating for 
sealing pores through the sol-gel method [75]. The authors 
conclude that the resistance to biodegradation in Hanks 
solution increases significantly —approximately 30 times— 
compared to uncoated magnesium only. The parameters of 
corrosion resistance were determined by electrochemical 
impedance spectroscopy and polarization assay after 12 
hours of immersion in the solution. The authors also 
demonstrated that the coating provided a more stable surface 
over time. 
Similarly, the study of coatings with nano silica-titanium 
dioxide on a Mg-Ca alloy by means of physical vapor 
deposition (PVD) has been reported. Coatings based on nano 
silica only were also evaluated. Electrochemical studies in 
simulated body fluid (SBF) showed that the nano Si / TiO2 
surface presents a significant reduction in corrosion rates 
(0.57 mm / year), when compared to the sample coated with 
nano silica only (0.91 mm / year), or the uncoated sample 
(6.21 mm / year). Likewise, a low hydrogen evolution was 
also observed [76]. 
 
3.2.  Sol-gel 
 
The sol-gel method is an efficient alternative to obtain 
coatings on different materials, since it provides low-cost 
coatings with good adhesion [77]. The method also enables 
to control the structure of the materials at the nanoscale and 
it can be used to produce metal oxides. 
Such method starts with the formation of a colloidal 
suspension of a molecular precursor in a solvent (sol) and a 
subsequent oxide network formation produced at low 
temperatures. The process involves two phases, signaled by 
the hydrolysis and condensation of the suspension and a 
polycondensation reaction that results in a three-dimensional 
network. The solvent is then removed from the gel by a 
drying process at room temperature (aging). Then, a heat 
treatment is applied to obtain monoliths or thin films. The 
sol-gel transition depends on the amount of precursors, water, 
catalyst, temperature and pH [78]. 
Several authors have used sol-gel methods for 
synthesizing TiO2 coatings. For example, Wang et al. [79] 
proposed a new method of dip/spin coating by sol-gel to 
prepare ultrafine titanium oxide films on α-Al2O3 disks. The 
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method was different from others since the substrate was first 
immersed in the sol and it was subsequently removed to form 
a thin coating by spinning. The authors obtained small glass 
films with uniform grains and a unique structure. Advincula 
et al. [80] employed a sol-gel process to prepare titanium 
oxide ultrafine silicon wafers. Those coatings were later 
modified by self-assembled monolayers (SAM) of silanes 
with different functional groups, in order to evaluate their in-
vitro protein adsorption behavior. The sol-gel process 
presents the advantage of accurately controlling the 
nanostructure and the thickness of these thin coatings. The 
authors suggested that surface modification with TiO2 by sol-
gel and SAMs can promote protein adsorption in vitro, due 
to changes in the surface chemical composition, roughness, 
and wettability. Subsequently, Advincula et al. [81] 
evaluated the biological response of the titanium oxide 
matrix derived from sol-gel, reporting an increase in cell 
adhesion and matrix mineralization on the substrates. The 
adequate cellular response of titanium oxide by sol-gel has 
been described by other authors [82,83]. In addition, the 
literature has also reported [22,84] that sol-gel-prepared 
titanium dioxide is able to induce calcium phosphates 
formation on TiO2 surfaces, improving the adhesion of the 
material to the biological tissue. 
 
3.2.1.  Surface modification of magnesium with titanium 
dioxide by sol-gel 
 
Titanium oxide coatings obtained by sol-gel have shown 
promising results. Recently, Li et al. [85] evaluated the 
corrosion resistance of coatings based on HA/TiO2 / PLA. 
Titanium dioxide was used as an intermediate layer and it 
provided high adhesion between the hydroxyapatite and the 
poly (lactic acid). The surface modification was obtained by 
the sol-gel technique through the dip-coating method, and the 
corrosion resistance of the studied surface improved when 
compared to uncoated substrates. 
Different authors have evaluated surface modification of 
magnesium with titanium dioxide by the sol-gel technique. 
One of the studies was carried out by Ochsenbein et al. [83]. 
They analyzed the response of osteoblasts to different oxide 
coatings obtained by sol-gel, and the results showed that 
titanium dioxide fostered proliferation and cell adhesion after 
three days of incubation. Another similar study performed by 
Hu et al. [86] showed an anticorrosive effect of TiO2 coatings 
obtained by sol-gel on an AZ31 magnesium alloy with 
potential use in strong acidic environments. Furthermore, Hu 
et al. [87] assessed the in-vitro degradation of magnesium 
coated with a nano TiO2 film by sol-gel. They concluded that 
the corrosion current decreased by almost 3 orders of 
magnitude when compared to uncoated samples. 
Li et al. [88] also showed that TiO2 coatings obtained by 
the sol-gel method significantly improve the corrosion 
resistance of a Mg-Ca alloy in SBF. More recent studies 
evaluated titanium oxide and titanium oxide / calcium 
phosphate coatings on AZ31 by the sol-gel method. Tang et 
al. [89] observed that the coatings improved the corrosion 
resistance and reduced the amount of hydrogen produced by 
magnesium corrosion. Although hydrogen bubbles are 
naturally created during degradation processes of magnesium 
alloys, the amount of hydrogen produced can decrease when 
the coating acts as a protection barrier. Corrosion studies 
were carried out in the solution of simulated body fluid 
(SBF). Moreover, Hernández et al [90] synthesized hybrid 
coatings by a mixture of organic precursors, inorganic 
glycidoxypropyltriethoxysilane (GPTMS), 3-
aminopropyltriethoxysilane (APTES), and tetraethyl 
orthosilicate (TEOS) by the sol-gel route, in order to increase 
the corrosion resistance of the WE54-AE magnesium alloy. 
Generally speaking, the results showed a significant 
improvement in the corrosion current by about one order of 
magnitude. 
In biomedical engineering, the improvement obtained by 
coatings on magnesium alloys can also be observed in the 
increase of cellular activity. The literature reports few studies 
on the biological properties of TiO2 substrates on 
magnesium. Still, some reports are available. Amaravathy et 
al. [91] successfully obtained sol-gel TiO2 coatings on a 
magnesium alloy —AZ31— and the results showed a 
significant improvement in adhesion during biological 
assessments. In addition, coated Mg exhibited a higher cell 
interaction (interaction area with the tissue) when compared 
to the unmodified alloy. Similarly, Amaravathy el al. [92] 
evaluated the coatings of titanium dioxide / hydroxyapatite 
on the magnesium alloy AZ31. The results of hydrogen 
evolution and potentiodynamic polarization studies showed 
that the coatings can act as a protective layer, decelerating the 
entry of corrosive metal ions from the SBF solution. 
Furthermore, cell cultures revealed that biocompatibility and 
cell adhesion of Mg coated with HA / TiO2 —evaluated by 
the osteoblast cell line MG63— improved significantly, 
which makes it a promising coating to induce 
osteointegration properties. TiO2 coatings on magnesium 
alloys usually create porous surfaces that may be unfavorable 
for applications of magnesium as orthopedic biomaterial. 
Surface defects may favor the rapid degradation of 
magnesium alloys. This problem has been solved by 
generating TiO2 multilayers on the Mg alloys. It has been 
described that a chemically alternated multilayer 
configuration generates greater resistance to corrosion [69]. 
Besides, it has also been reported that a correct densification 
of the TiO2 film prevents the formation of surfaces with pores 
or cracks [87]. New strategies include the use of bilayer-
coatings and hybrid multilayer coatings using TiO2 and 
alumina [69] and TiO2 and hydroxyapatite [92] as coating 
materials. 
 
4.  Conclusions 
 
Surface modification techniques are an important area in 
biomaterials research and biomedical engineering of 
magnesium alloys. By surface modification of magnesium 
and its alloys the biocompatibility can be enhanced and 
problems related to degradation of magnesium can be 
overcome while maintaining the bulk properties. Therefore, 
this paper reviewed TiO2 coatings used to improve the 
biological and corrosion resistance of magnesium and its 
alloys. 
Research carried out during the previous 5 years has 
shown that the corrosion resistance and biological properties 
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in the tissue-biomaterial interface of magnesium and its 
alloys may be selectively enhanced using appropriate surface 
treatments. Coatings obtained by sol-gel methods have 
proven to be attractive due to their low processing costs and 
because they enable to obtain homogeneous surfaces to 
decrease the degradation rate of the implant. Some studies 
have also reported that this technique can be used to create 
antibacterial surfaces, if suitable precursors are used. 
Although there are multiple surface modification 
techniques to generate coatings on magnesium, considerable 
research efforts are still needed to meet the current clinical 
needs of biodegradable medical implants. Currently, there are 
no coatings on magnesium capable of maintaining 
mechanical integrity for the time needed by the bone tissue 
to heal and subsequently be successfully degraded. More 
efforts are needed to understand the interaction of 
magnesium coated with TiO2 with biological systems (mainly 
with cell lines derived from bone). There also are few studies 
available in the literature with results of the performance of 
in-vivo animal models. Likewise, studies showing 
antibacterial properties of coatings on magnesium are still 
under development. 
Overall developments of new biodegradable magnesium 
alloys for medical use are based on the control of the 
corrosion rate and, thereby, the mechanical integrity of the 
material in a physiological environment. Several research 
papers published during the previous 5 years showed that 
coatings with titanium dioxide significantly improve the 
surface properties of magnesium. Surface treatments with 
new and innovative materials can reduce the corrosion rate 
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